<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T10:24:54Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/7444" metadataPrefix="mods">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/7444</identifier><datestamp>2026-02-06T12:53:36Z</datestamp><setSpec>com_10259_4363</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>com_10259_3924</setSpec><setSpec>com_10259.4_2516</setSpec><setSpec>com_10259_3592</setSpec><setSpec>com_10259_3591</setSpec><setSpec>com_10259.4_106</setSpec><setSpec>col_10259_4364</setSpec><setSpec>col_10259_3925</setSpec><setSpec>col_10259.4_2517</setSpec><setSpec>col_10259_3930</setSpec></header><metadata><mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:namePart>Echevarría Poza, Igor</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Zafon, Elisenda</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Barrabés, Sílvia</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Martínez, María Ángeles</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Ramos Gómez, Sonia</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Ortega Santamaría, Natividad</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Manzano, Blanca R.</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Jalón Sotés, Félix Ángel</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Quesada Pato, Roberto</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Espino Ordóñez, Gustavo</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Massaguer Vall-Llovera, Anna</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2023-02-13T11:43:03Z</mods:dateAvailable>
</mods:extension>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2023-02-13T11:43:03Z</mods:dateAccessioned>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2022-06</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="issn">0162-0134</mods:identifier>
<mods:identifier type="uri">http://hdl.handle.net/10259/7444</mods:identifier>
<mods:identifier type="doi">10.1016/j.jinorgbio.2022.111790</mods:identifier>
<mods:abstract>Despite their outstanding properties as potential photosensitizers for photodynamic therapy (PDT), Ir(III) biscyclometalated complexes need both further developments to overcome remaining limitations and in-depth&#xd;
investigations into their mechanisms of action to reach clinic application in the treatment of cancer. This&#xd;
work describes the synthesis of a family of Ir(III) complexes of general formula [Ir(C^N)2(N^N′&#xd;
)]Cl (N^N′ =&#xd;
thiabendazole-based ligands; C^N = ppy (2-phenylpyridinate) (Series A), or dfppy (2-(2,4-difluorophenyl)pyridinate) (Series B)) and their evaluation as potential PDT agents. These complexes are partially soluble in water&#xd;
and exhibit cytotoxic activity in the absence of light irradiation versus several cancer cell lines. Furthermore, the&#xd;
cytotoxic activity of derivatives of Series A is enhanced upon irradiation, particularly for complexes [1a]Cl and&#xd;
[3a]Cl, which show phototoxicity indexes (PI) above 20. Endocytosis was established as the uptake mechanism&#xd;
for [1a]Cl and [3a]Cl in prostate cancer cells by flow cytometry. These derivatives mainly accumulate in the&#xd;
mitochondria as shown by colocalization confocal microscopy experiments. Presumably, [1a]Cl and [3a]Cl&#xd;
induce death on cancer cells under irradiation through apoptosis triggered by a multimodal mechanism of action,&#xd;
which likely involves damage over mitochondrial DNA and mitochondrial membrane depolarization. Both&#xd;
processes seem to be the result of photocatalytic oxidation processes.</mods:abstract>
<mods:language>
<mods:languageTerm>eng</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">http://creativecommons.org/licenses/by-nc-nd/4.0/</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">info:eu-repo/semantics/openAccess</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">Attribution-NonCommercial-NoDerivatives 4.0 Internacional</mods:accessCondition>
<mods:subject>
<mods:topic>Photodynamic therapy</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Iridium</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Cyclometalated complexes</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Cancer</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Mitochondria</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>DNA</mods:topic>
</mods:subject>
<mods:titleInfo>
<mods:title>Rational design of mitochondria targeted thiabendazole-based Ir(III) biscyclometalated complexes for a multimodal photodynamic therapy of cancer</mods:title>
</mods:titleInfo>
<mods:genre>info:eu-repo/semantics/article</mods:genre>
</mods:mods></metadata></record></GetRecord></OAI-PMH>